These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28581463)

  • 41. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
    Martin AR; Pearson JD; Cai B; Elmer M; Horgan K; Lindley C
    Support Care Cancer; 2003 Aug; 11(8):522-7. PubMed ID: 12827483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute and delayed nausea and emesis control in pediatric oncology patients.
    Holdsworth MT; Raisch DW; Frost J
    Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of Aprepitant (Emend®) to Standard Antiemetic Regimen Continued for 7 Days after Chemotherapy for Stem Cell Transplantation Provides Significant Reduction of Vomiting.
    Svanberg A; Birgegård G
    Oncology; 2015; 89(1):31-6. PubMed ID: 25659986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention and management of chemotherapy-induced nausea and vomiting.
    Moradian S; Howell D
    Int J Palliat Nurs; 2015 May; 21(5):216, 218-24. PubMed ID: 26107543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
    Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
    Grunberg SM; Rolski J; Strausz J; Aziz Z; Lane S; Russo MW; Wissel P; Guckert M; Wright O; Herrstedt J
    Lancet Oncol; 2009 Jun; 10(6):549-58. PubMed ID: 19428297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.
    Ballen KK; Hesketh AM; Heyes C; Becker PS; Emmons RV; Fogarty K; LaPointe J; Liu Q; Hsieh CC; Hesketh PJ
    Bone Marrow Transplant; 2001 Dec; 28(11):1061-6. PubMed ID: 11781617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
    Navari RM; Einhorn LH; Loehrer PJ; Passik SD; Vinson J; McClean J; Chowhan N; Hanna NH; Johnson CS
    Support Care Cancer; 2007 Nov; 15(11):1285. PubMed ID: 17375339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy.
    Dupuis LL; Tamura RN; Kelly KM; Krischer JP; Langevin AM; Chen L; Kolb EA; Ullrich NJ; Sahler OJZ; Hendershot E; Stratton A; Sung L; McLean TW
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27584. PubMed ID: 30561134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.
    Molassiotis A; Coventry PA; Stricker CT; Clements C; Eaby B; Velders L; Rittenberg C; Gralla RJ
    J Pain Symptom Manage; 2007 Aug; 34(2):148-59. PubMed ID: 17509816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer.
    Jung D; Lee KM; Kim WH; Lee JY; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ
    Psychosom Med; 2016 Oct; 78(8):959-965. PubMed ID: 27428859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: a retrospective, multi-center review.
    Flank J; Thackray J; Nielson D; August A; Schechter T; Alexander S; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2015 Mar; 62(3):496-501. PubMed ID: 25328089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Preliminary Effects of Massage and Inhalation Aromatherapy on Chemotherapy-Induced Acute Nausea and Vomiting: A Quasi-Randomized Controlled Pilot Trial.
    Zorba P; Ozdemir L
    Cancer Nurs; 2018; 41(5):359-366. PubMed ID: 28426542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taste changes in children with cancer and hematopoietic stem cell transplant recipients.
    Loves R; Tomlinson D; Baggott C; Dix D; Gibson P; Hyslop S; Johnston DL; Orsey AD; Portwine C; Price V; Schechter T; Vanan M; Kuczynski S; Spiegler B; Tomlinson GA; Dupuis LL; Sung L
    Support Care Cancer; 2019 Jun; 27(6):2247-2254. PubMed ID: 30324284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy-induced nausea and vomiting from oral chemotherapy for childhood acute lymphoblastic leukaemia: feasibility study.
    Kovacevic A; Sivananthan A; Patel R; Patel P; Vennettilli A; Paw Cho Sing E; Zupanec S; Alexander S; Sung L; Dupuis LL
    BMJ Support Palliat Care; 2022 Nov; 12(e5):e646-e649. PubMed ID: 31784465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determining the factors affecting chemotherapy-induced nausea and vomiting in children with cancer.
    Ay A; Boztepe H; Özbay SÇ; Yılmaz P; Karadavut B; Burhanoğulları D; Akyüz C
    J Pediatr Nurs; 2023; 73():e426-e434. PubMed ID: 37845092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.